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1. INTRODUCTION {#pd5421-sec-0005}
===============

The last 35 years have witnessed an expansion of fetal therapy options,[1](#pd5421-bib-0001){ref-type="ref"}, [2](#pd5421-bib-0002){ref-type="ref"} with surgery on the fetus, placenta, or cord now relatively common in tertiary‐level fetal medicine units. Enabled by advancements in imaging, surgical instrumentation and techniques, early diagnosis, and treatment of fetal anomalies are now possible for a wide range of conditions.[3](#pd5421-bib-0003){ref-type="ref"}

The mother has been called an "innocent bystander" in fetal surgery,[4](#pd5421-bib-0004){ref-type="ref"} and generally, fetal therapy is almost exclusively offered to women who are healthy themselves. Fetal surgery poses risks to the mother not only during the procedure itself but also throughout the remainder of the index pregnancy, potentially during any future pregnancies and throughout the woman\'s entire life. Fetal surgery offers no direct medical benefit to the mother, and from an ethical perspective, maternal risks should be minor and acceptable to the mother and family.[5](#pd5421-bib-0005){ref-type="ref"}

Information regarding safety of surgery is important for counselling and informed decision making; however, robust data on maternal complications of fetal surgery are lacking. One single‐centre study of maternal outcomes following both open fetal and fetoscopic surgery performed between 1989 and 2003 found a number of short‐term morbidities.[6](#pd5421-bib-0006){ref-type="ref"} A systematic review of maternal complications following fetoscopic laser coagulation for twin‐to‐twin transfusion syndrome (TTTS) in 1785 patients treated between[7](#pd5421-bib-0007){ref-type="ref"} 1990 and 2009 observed an overall adverse event rate of 5.4% with severe complications in 1.0%. The aim of this study was to estimate the incidence of immediate and long‐term maternal complications of fetoscopic or open fetal surgery through a systematic review of the literature.

What\'s already known about this topic? {#pd5421-sec-1007}
---------------------------------------

Fetal surgery, both open and fetoscopic, is now widely performed.Fetoscopy is perceived as safe for the mother, although specific data on maternal complications is lacking.Open fetal surgery is known to cause maternal morbidity, but the exact nature and frequency of complications is not well established across different centres and types of surgery.

What does this study add? {#pd5421-sec-2007}
-------------------------

This study estimates the nature and frequency of maternal complications following fetoscopic and open fetal surgery.For open fetal surgery, the severe complication rate (grades III to V according to the Clavien‐Dindo classification of surgical complications) is approximately 4% and minor complication rate is 16%.For fetoscopic fetal surgery, the severe complication rate is approximately 2% and minor complication rate is 4%.

2. METHODS {#pd5421-sec-0007}
==========

2.1. Protocol and registration {#pd5421-sec-0008}
------------------------------

This systematic review was conducted in accordance with preferred reporting items for systematic reviews and meta‐analyses (PRISMA) guidance.[8](#pd5421-bib-0008){ref-type="ref"} The protocol was registered with the international prospective register of systematic reviews (PROSPERO‐CRD42017082411).

2.2. Eligibility criteria {#pd5421-sec-0009}
-------------------------

All randomised, cohort, and case‐controlled studies and case series reporting the results of open fetal or fetoscopic fetal surgery in humans from January 1990 to October 2018 were considered eligible. No language restrictions were applied. Systematic reviews, narrative review articles, and case reports were excluded. There is no accepted numerical definition of a case series.[9](#pd5421-bib-0009){ref-type="ref"} We used an empirical cut‐off of at least three cases because of the rarity of some procedures and conditions searched for.

2.3. Search strategy {#pd5421-sec-0010}
--------------------

A systematic review was conducted in MEDLINE, EMBASE, and Cochrane databases using free text and Medical Subject Headings (MESH). The electronic search strategy is described in the [Supporting Information](#pd5421-supitem-0001){ref-type="supplementary-material"}. Subsequently, a grey literature (first 100 hits in PubMed and Google Scholar) search was performed, and reference lists of relevant review articles were manually checked. Covidence software (Veritas Health Innovation Ltd, Melbourne, Australia) was used to eliminate duplicate articles and manage study screening.

2.4. Study selection {#pd5421-sec-0011}
--------------------

Two authors (A.S. and L.VdV.) screened all titles and abstracts independently, excluded irrelevant studies and then independently assessed the remaining full‐text articles for eligibility; disagreements were resolved by consensus. Studies were excluded if the full text was unavailable online and the abstract contained insufficient information. Studies with interventions which were not fully described or were performed on the neonate instead of the fetus were excluded. Interventions involving access to the uterus using a device with a total outer diameter of less than 1.5 mm were excluded; this cut‐off was chosen to avoid procedures performed with needles only (eg, amniocentesis, fetal blood transfusion, thoracocentesis or vesicocentesis). Studies of shunting were only included if the outer shunt diameter was greater than or equal to 1.5 mm or the shunt was inserted fetoscopically. Studies which did not report maternal outcomes were excluded. For the purpose of this study, preterm rupture of membranes (PROM), chorionic membrane separation (CMS), preterm labour, preterm delivery, and gestational age at delivery, although relevant, were not considered to be maternal complications. Studies from which data could not be extracted (eg, composite or combined outcomes given) and studies containing patient cohorts which appeared to have been published previously by the same authors were excluded.

2.5. Data extraction {#pd5421-sec-0012}
--------------------

Two authors independently extracted data (A.S. and E.B. for open fetal surgery studies, A.S. and C.F. for fetoscopic studies) and entered them into a standardised Excel (Microsoft, Washington, USA) form. Disagreements were resolved by consensus. The ex utero intrapartum treatment (EXIT) procedure was classified as open fetal surgery. Study characteristics noted included study design, underlying fetal condition, type of intervention, presence of a control group, gestational age at surgery, and number of patients in each study. Outcomes recorded for the duration of the index pregnancy included intraoperative complications (maternal death, placental abruption, uterine bleeding/haemorrhage, blood transfusion, organ damage, or anaesthetic complications), post‐operative complications (classified from the end of surgery until delivery; maternal death, placental abruption, uterine bleeding/haemorrhage, blood transfusion, sepsis, chorioamnionitis, other infections, pulmonary oedema, amniotic fluid embolism and other respiratory, gastro‐intestinal, cardiac, or wound problems), complications at delivery of the index pregnancy (uterine dehiscence or rupture or blood transfusion), and the need for additional treatment at any time during the pregnancy. Outcomes noted at any time following the index pregnancy (late outcomes) included fertility (number of further pregnancies, difficulty conceiving, mean time to conception), future pregnancy complications (miscarriage or preterm delivery), complications during future deliveries (uterine dehiscence or rupture or haemorrhage at delivery), gynaecological and psychological symptoms. When a study reported "haemorrhage" or an actual blood loss of greater than 1000 mL we noted this as "haemorrhage." This cut‐off is an accepted definition of severe bleeding both in pregnancy[10](#pd5421-bib-0010){ref-type="ref"} and post‐partum.[11](#pd5421-bib-0011){ref-type="ref"} If a study did not specify whether a complication occurred intraoperatively or post‐operatively (eg, placental abruption and requirement for blood transfusion), then this was assumed to have occurred post‐operatively.

All complications were independently graded according to the Clavien‐Dindo classification of surgical complications[12](#pd5421-bib-0012){ref-type="ref"} by two authors (A.S. and L.VdV.) ([Supporting Information](#pd5421-supitem-0001){ref-type="supplementary-material"}). Clavien‐Dindo grade I or II complications were defined as mild; grades III to V complications were defined as severe.[12](#pd5421-bib-0012){ref-type="ref"}

2.6. Quality assessment of studies {#pd5421-sec-0013}
----------------------------------

Study quality and risk of bias were analysed by two authors (A.S. and L.VdV.) independently using a standardised form. Randomised trials were analysed using the Cochrane Collaboration\'s tool for assessing risk of bias.[13](#pd5421-bib-0013){ref-type="ref"} Case‐control studies were analysed using the Newcastle‐Ottawa scale for assessing the quality of nonrandomised studies.[14](#pd5421-bib-0014){ref-type="ref"} Case series were analysed using the National Institutes of Health study quality assessment tool.[15](#pd5421-bib-0015){ref-type="ref"}

2.7. Assessment of heterogeneity {#pd5421-sec-0014}
--------------------------------

Methodological and clinical heterogeneity of data per study were evaluated. Variables were tested for statistical heterogeneity by applying the I^2^ test to determine whether data could be pooled. An I^2^ value less than 40% was taken to indicate minor heterogeneity; 40% to 75% moderate heterogeneity and greater than 75% substantial heterogeneity.[13](#pd5421-bib-0013){ref-type="ref"}

2.8. Meta‐analysis {#pd5421-sec-0015}
------------------

Meta‐analysis for all outcomes was carried out using MedCalc statistical software version 15.4 (MedCalc Software, Ostend, Belgium). Results were expressed as proportions with 95% confidence intervals (CI) as all outcomes were categorical variables. Pooled proportions were calculated using both the fixed and random effects model in case of homogeneity or heterogeneity respectively.

3. RESULTS {#pd5421-sec-0016}
==========

3.1. Study selection {#pd5421-sec-0017}
--------------------

The electronic literature search identified 70 367 studies published between 1990 and 2018 (Figure [1](#pd5421-fig-0001){ref-type="fig"}); search of the grey literature and reference lists identified a further 16 studies. Following this, 48 248 studies were immediately removed as duplicates. The remaining studies (22 135) were screened by title and abstract, and a further 21 384 were excluded as irrelevant. Full texts of the remaining 751 articles were reviewed, and 585 were excluded for the following reasons: no reporting of maternal outcomes (175/585, 29.9% of studies excluded and 23.3% \[175/751\] of all studies assessed), insufficient information available (conference abstract/poster only or full text unavailable) (119/585, 20.3%), study design other than randomised trial, case‐control trial or case series (110/585, 18.8%), and uterine access using a device less than 1.5 mm (59/585, 10.1%). Thirty studies were translated from French (10), Spanish (seven), Polish (five), German (three), Dutch (two), Portuguese (two), and Turkish (one), of which 16 were included following review. Two Chinese‐language papers were identified, but the full text could not be accessed online. Eventually, 166 studies were included; 41 on open fetal surgery, 122 on fetoscopic surgery, and three studies including both surgery types.

![Flow diagram of study selection adapted from preferred reporting items for systematic reviews and meta‐analyses (PRISMA)[8](#pd5421-bib-0008){ref-type="ref"} 2009](PD-39-251-g001){#pd5421-fig-0001}

3.2. Study characteristics {#pd5421-sec-0018}
--------------------------

Characteristics of included studies are shown in Tables [1](#pd5421-tbl-0001){ref-type="table"}, [2](#pd5421-tbl-0002){ref-type="table"}, [3](#pd5421-tbl-0003){ref-type="table"}. Studies of open fetal (Table [1](#pd5421-tbl-0001){ref-type="table"}) and fetoscopic (Table [2](#pd5421-tbl-0002){ref-type="table"}) surgery are presented and analysed separately as the difference in surgical technique was considered too great for combined analysis. Seven studies specifically focused on late complications, ie, after the index pregnancy and are presented separately (Table [3](#pd5421-tbl-0003){ref-type="table"}). The majority of studies (68.1%, 113/166) were case series, ie, without a control group; 27.1% (45/166) were case control studies, and 4.8% (8/166) were randomised trials.

###### 

Included studies of open fetal surgery

  Category                                                                                    First Author and Year of Publication                                                                                               Condition              Procedure              Study Design   No of Patients
  ------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- ---------------------- ---------------------- -------------- ----------------
  EXIT                                                                                        Barthod,[16](#pd5421-bib-0016){ref-type="ref"} 2013                                                                                Neck mass, CHAOS       EXIT                   Case series    5
  Cass,[17](#pd5421-bib-0017){ref-type="ref"} 2013                                            Lung mass, mediastinal mass                                                                                                        EXIT                   Case series            9              
  Chen,[18](#pd5421-bib-0018){ref-type="ref"} 2018                                            Omphalocele                                                                                                                        EXIT                   Case control           7              
  Dahlgren,[19](#pd5421-bib-0019){ref-type="ref"} 2004                                        Head or neck tumour                                                                                                                EXIT                   Case series            4              
  Flake,[20](#pd5421-bib-0020){ref-type="ref"} 2000[a](#pd5421-note-0001){ref-type="fn"}      CDH                                                                                                                                EXIT                   Case series            15             
  George,[21](#pd5421-bib-0021){ref-type="ref"} 2007                                          Skeletal dysplasia, micrognathia                                                                                                   EXIT                   Case series            3              
  Hedrick,[22](#pd5421-bib-0022){ref-type="ref"} 2003                                         Multiple                                                                                                                           EXIT                   Case series            43             
  Hedrick,[23](#pd5421-bib-0023){ref-type="ref"} 2005                                         Lung lesions                                                                                                                       EXIT                   Case series            9              
  Kern,[24](#pd5421-bib-0024){ref-type="ref"} 2007                                            CCAM, hydrothorax                                                                                                                  EXIT                   Case series            5              
  Kornacki,[25](#pd5421-bib-0025){ref-type="ref"} 2017                                        Neck mass, CHAOS                                                                                                                   EXIT                   Case series            4              
  Kunisaki,[26](#pd5421-bib-0026){ref-type="ref"} 2007                                        CDH                                                                                                                                EXIT                   Case control           14             
  Laje,[27](#pd5421-bib-0027){ref-type="ref"} 2012                                            Cervical teratoma                                                                                                                  EXIT                   Case series            17             
  Laje,[28](#pd5421-bib-0028){ref-type="ref"} 2013                                            Neck mass                                                                                                                          EXIT                   Case series            4              
  Laje,[29](#pd5421-bib-0029){ref-type="ref"} 2015                                            Cervical lymphatic mass                                                                                                            EXIT                   Case series            13             
  Lazar,[30](#pd5421-bib-0030){ref-type="ref"} 2011                                           Neck mass                                                                                                                          EXIT                   Case series            12             
  Noah,[31](#pd5421-bib-0031){ref-type="ref"} 2002                                            Not stated                                                                                                                         EXIT                   Case control           34             
  Pellicer,[32](#pd5421-bib-0032){ref-type="ref"} 2007                                        Neck mass                                                                                                                          EXIT                   Case series            3              
  Stoffan,[33](#pd5421-bib-0033){ref-type="ref"} 2012                                         CDH                                                                                                                                EXIT                   Case control           7              
  Tuncay Ozgunen,[34](#pd5421-bib-0034){ref-type="ref"} 2010                                  Neck mass                                                                                                                          EXIT                   Case series            3              
  Zamora,[35](#pd5421-bib-0035){ref-type="ref"} 2013[c](#pd5421-note-0003){ref-type="fn"}     MMC, lung mass, SCT                                                                                                                EXIT                   Case series            26             
  MMC                                                                                         Bennett,[36](#pd5421-bib-0036){ref-type="ref"} 2014                                                                                MMC                    Neurosurgical repair   Case control   43
  Botelho,[37](#pd5421-bib-0037){ref-type="ref"} 2017                                         MMC                                                                                                                                Neurosurgical repair   Case series            45             
  Bruner,[38](#pd5421-bib-0038){ref-type="ref"} 1999                                          MMC                                                                                                                                Neurosurgical repair   Case control           29             
  Bruner,[39](#pd5421-bib-0039){ref-type="ref"} 2000[c](#pd5421-note-0003){ref-type="fn"}     MMC                                                                                                                                Neurosurgical repair   Case control           4              
  Farmer,[40](#pd5421-bib-0040){ref-type="ref"} 2003                                          MMC                                                                                                                                Neurosurgical repair   Case series            12             
  Friszer,[41](#pd5421-bib-0041){ref-type="ref"} 2016                                         MMC                                                                                                                                Neurosurgical repair   Case series            3              
  Johnson,[42](#pd5421-bib-0042){ref-type="ref"} 2016                                         MMC                                                                                                                                Neurosurgical repair   Randomised             91             
  Marenco,[43](#pd5421-bib-0043){ref-type="ref"} 2013                                         MMC                                                                                                                                Neurosurgical repair   Case series            4              
  Moldenhauer,[44](#pd5421-bib-0044){ref-type="ref"} 2015                                     MMC                                                                                                                                Neurosurgical repair   Case series            100            
  Moron,[45](#pd5421-bib-0045){ref-type="ref"} 2018                                           MMC                                                                                                                                Neurosurgical repair   Case series            237            
  Ochsenbein‐Kolble,[46](#pd5421-bib-0046){ref-type="ref"} 2017                               MMC                                                                                                                                Neurosurgical repair   Case control           30             
  Sinskey,[47](#pd5421-bib-0047){ref-type="ref"} 2017                                         MMC                                                                                                                                Neurosurgical repair   Case series            47             
  Soni,[48](#pd5421-bib-0048){ref-type="ref"} 2016                                            MMC                                                                                                                                Neurosurgical repair   Case series            88             
  Zamlynski,[49](#pd5421-bib-0049){ref-type="ref"} 2014                                       MMC                                                                                                                                Neurosurgical repair   Case control           46             
  CDH                                                                                         Flake,[20](#pd5421-bib-0020){ref-type="ref"} 2000[a](#pd5421-note-0001){ref-type="fn"}                                             CDH                    Tracheal occlusion     Case series    15
  Harrison,[50](#pd5421-bib-0050){ref-type="ref"} 1990                                        CDH                                                                                                                                Diaphragm repair       Case series            6              
  Harrison,[51](#pd5421-bib-0051){ref-type="ref"} 1993                                        CDH                                                                                                                                Diaphragm repair       Case series            14             
  Harrison,[52](#pd5421-bib-0052){ref-type="ref"} 1998[b](#pd5421-note-0002){ref-type="fn"}   CDH                                                                                                                                Tracheal occlusion     Case control           13             
  CCAM                                                                                        Adzick,[53](#pd5421-bib-0053){ref-type="ref"} 2003                                                                                 CCAM                   Lung resection         Case series    22
  SCT                                                                                         Hedrick,[54](#pd5421-bib-0054){ref-type="ref"} 2004                                                                                SCT                    Debulking              Case series    4
  Mixed                                                                                       Golombeck,[6](#pd5421-bib-0006){ref-type="ref"} 2006[a](#pd5421-note-0001){ref-type="fn"}, [b](#pd5421-note-0002){ref-type="fn"}   MMC, CCAM, SCT         Mixed                  Case control   79
  Longaker,[55](#pd5421-bib-0055){ref-type="ref"} 1991                                        LUTO, CDH, SCT, CCAM                                                                                                               Mixed                  Case series            17             
  Zamora,[35](#pd5421-bib-0035){ref-type="ref"} 2013[c](#pd5421-note-0003){ref-type="fn"}     MMC, lung mass, SCT                                                                                                                Mixed                  Case series            7              
  TOTAL                                                                                                                                                                                                                                                                        43 studies     1193 patients

Abbreviations: CCAM, congenital cystic adenomatoid malformation; CD, congenital diaphragmatic hernia; CHAOS, congenital high airway obstruction syndrome; EXIT, ex utero intrapartum treatment; LUTO, lower urinary tract obstruction; MMC, myelomeningocele; SCT, sacrococcygeal teratoma.

Studies including patients undergoing a primary fetal and later an EXIT procedure.

Studies including both open and fetoscopic procedures also included in Table [2](#pd5421-tbl-0002){ref-type="table"}.

Studies including immediate and late complications also included in Table [3](#pd5421-tbl-0003){ref-type="table"}.

###### 

Included studies of fetoscopic surgery

  Category                                                                                    First Author and Year of Publication                                                        Condition                                               Procedure                 Study Design   No of Patients
  ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------- ------------------------- -------------- ----------------
  Multiple pregnancy complications treated with laser                                         Aboudiab,[56](#pd5421-bib-0056){ref-type="ref"} 2017                                        TTTS                                                    Laser photocoagulation    Case series    18
  Baschat,[57](#pd5421-bib-0057){ref-type="ref"} 2013                                         TTTS                                                                                        Laser photocoagulation                                  Case control              147            
  Chalouhi,[58](#pd5421-bib-0058){ref-type="ref"} 2016                                        TTTS (triplets)                                                                             Laser photocoagulation                                  Case series               22             
  Chang,[59](#pd5421-bib-0059){ref-type="ref"} 2006                                           TTTS                                                                                        Laser photocoagulation                                  Case series               27             
  Chang,[60](#pd5421-bib-0060){ref-type="ref"} 2016                                           TTTS                                                                                        Laser photocoagulation                                  Case control              100            
  Chmait,[61](#pd5421-bib-0061){ref-type="ref"} 2013                                          TTTS                                                                                        Laser photocoagulation                                  Case control              318            
  Chmait,[62](#pd5421-bib-0062){ref-type="ref"} 2017                                          TTTS                                                                                        Laser photocoagulation                                  Case series               19             
  Crombleholme,[63](#pd5421-bib-0063){ref-type="ref"} 2007                                    TTTS                                                                                        Laser photocoagulation                                  Randomised                20             
  De Lia,[64](#pd5421-bib-0064){ref-type="ref"} 1995                                          TTTS                                                                                        Laser photocoagulation                                  Case series               26             
  De Lia,[65](#pd5421-bib-0065){ref-type="ref"} 1999                                          TTTS                                                                                        Laser photocoagulation                                  Case series               67             
  De Lia,[66](#pd5421-bib-0066){ref-type="ref"} 2009                                          TTTS (triplets)                                                                             Laser photocoagulation                                  Case series               10             
  Deprest,[67](#pd5421-bib-0067){ref-type="ref"} 1998                                         TTTS                                                                                        Laser photocoagulation                                  Case series               6              
  Draga,[68](#pd5421-bib-0068){ref-type="ref"} 2016                                           TTTS                                                                                        Laser photocoagulation                                  Case series               37             
  Duron,[69](#pd5421-bib-0069){ref-type="ref"} 2014                                           TTTS                                                                                        Laser photocoagulation                                  Case control              85             
  Ek,[70](#pd5421-bib-0070){ref-type="ref"} 2012                                              TTTS                                                                                        Laser photocoagulation                                  Case series               67             
  Habli,[71](#pd5421-bib-0071){ref-type="ref"} 2009                                           TTTS                                                                                        Laser photocoagulation                                  Case series               152            
  Has,[72](#pd5421-bib-0072){ref-type="ref"} 2014                                             TTTS                                                                                        Laser photocoagulation                                  Case series               85             
  Hecher,[73](#pd5421-bib-0073){ref-type="ref"} 2000                                          TTTS                                                                                        Laser photocoagulation                                  Case control              200            
  Hernandez‐Andrade,[74](#pd5421-bib-0074){ref-type="ref"} 2011                               TTTS                                                                                        Laser photocoagulation                                  Case series               35             
  Huber,[75](#pd5421-bib-0075){ref-type="ref"} 2008                                           TTTS                                                                                        Laser photocoagulation                                  Case control              176            
  Ishii,[76](#pd5421-bib-0076){ref-type="ref"} 2014                                           TTTS (triplets)                                                                             Laser photocoagulation                                  Case series               16             
  Ishii,[77](#pd5421-bib-0077){ref-type="ref"} 2015                                           sFGR                                                                                        Laser photocoagulation                                  Case series               10             
  Lanna,[78](#pd5421-bib-0078){ref-type="ref"} 2017                                           TTTS                                                                                        Laser photocoagulation                                  Case control              373            
  Lecointre,[79](#pd5421-bib-0079){ref-type="ref"} 2017                                       TTTS                                                                                        Laser photocoagulation                                  Case control              200            
  Malshe,[80](#pd5421-bib-0080){ref-type="ref"} 2017                                          TTTS                                                                                        Laser photocoagulation                                  Case series               203            
  Martinez,[81](#pd5421-bib-0081){ref-type="ref"} 2012                                        TTTS                                                                                        Laser photocoagulation                                  Case series               500            
  Middeldorp,[82](#pd5421-bib-0082){ref-type="ref"} 2007                                      TTTS                                                                                        Laser photocoagulation                                  Case series               100            
  Miyadahira,[83](#pd5421-bib-0083){ref-type="ref"} 2018                                      sFGR                                                                                        Laser photocoagulation                                  Case control              67             
  Molina‐Garcia,[84](#pd5421-bib-0084){ref-type="ref"} 2009                                   TTTS, sFGR                                                                                  Laser photocoagulation                                  Case series               22             
  Morris,[85](#pd5421-bib-0085){ref-type="ref"} 2010                                          TTTS                                                                                        Laser photocoagulation                                  Case series               164            
  Mullers,[86](#pd5421-bib-0086){ref-type="ref"} 2015                                         TTTS                                                                                        Laser photocoagulation                                  Case series               105            
  Nakata,[87](#pd5421-bib-0087){ref-type="ref"} 2016                                          TTTS                                                                                        Laser photocoagulation                                  Case series               6              
  Nguyen,[88](#pd5421-bib-0088){ref-type="ref"} 2012                                          TTTS                                                                                        Laser photocoagulation                                  Case series               98             
  Ozawa,[89](#pd5421-bib-0089){ref-type="ref"} 2017                                           Amniotic fluid discordance                                                                  Laser photocoagulation                                  Case series               11             
  Papanna,[90](#pd5421-bib-0090){ref-type="ref"} 2010                                         TTTS                                                                                        Laser photocoagulation                                  Case control              48             
  Papanna,[91](#pd5421-bib-0091){ref-type="ref"} 2012                                         TTTS                                                                                        Laser photocoagulation                                  Case control              163            
  Peeters,[92](#pd5421-bib-0092){ref-type="ref"} 2014                                         TTTS                                                                                        Laser photocoagulation                                  Case control              338            
  Persico,[93](#pd5421-bib-0093){ref-type="ref"} 2016                                         TTTS                                                                                        Laser photocoagulation                                  Case series               106            
  Quintero,[94](#pd5421-bib-0094){ref-type="ref"} 2000                                        TTTS                                                                                        Laser photocoagulation                                  Case control              92             
  Quintero,[95](#pd5421-bib-0095){ref-type="ref"} 2001                                        sFGR                                                                                        Laser photocoagulation                                  Case series               11             
  Rossi,[96](#pd5421-bib-0096){ref-type="ref"} 2008                                           TTTS                                                                                        Laser photocoagulation                                  Case control              266            
  Ruano,[97](#pd5421-bib-0097){ref-type="ref"} 2009                                           TTTS                                                                                        Laser photocoagulation                                  Case series               19             
  Ruegg,[98](#pd5421-bib-0098){ref-type="ref"} 2018                                           TTTS                                                                                        Laser photocoagulation                                  Case control              37             
  Rustico,[99](#pd5421-bib-0099){ref-type="ref"} 2012                                         TTTS                                                                                        Laser photocoagulation                                  Case series               150            
  Said,[100](#pd5421-bib-0100){ref-type="ref"} 2008                                           TTTS                                                                                        Laser photocoagulation                                  Case series               10             
  Senat,[101](#pd5421-bib-0101){ref-type="ref"} 2004                                          TTTS                                                                                        Laser photocoagulation                                  Randomised                72             
  Sepulveda,[102](#pd5421-bib-0102){ref-type="ref"} 2007                                      TTTS                                                                                        Laser photocoagulation                                  Case series               33             
  Shamshirsaz,[103](#pd5421-bib-0103){ref-type="ref"} 2015                                    TTTS                                                                                        Laser photocoagulation                                  Case control              55             
  Slaghekke,[104](#pd5421-bib-0104){ref-type="ref"} 2014                                      TTTS                                                                                        Laser photocoagulation                                  Randomised                274            
  Taniguchi,[105](#pd5421-bib-0105){ref-type="ref"} 2015                                      TTTS                                                                                        Laser photocoagulation                                  Case series               3              
  Tchirikov,[106](#pd5421-bib-0106){ref-type="ref"} 2011                                      TTTS                                                                                        Laser photocoagulation                                  Case control              80             
  Teoh,[107](#pd5421-bib-0107){ref-type="ref"} 2013                                           TTTS                                                                                        Laser photocoagulation                                  Case series               49             
  Thia,[108](#pd5421-bib-0108){ref-type="ref"} 2017                                           TTTS                                                                                        Laser photocoagulation                                  Case series               5              
  Ville,[109](#pd5421-bib-0109){ref-type="ref"} 1997                                          TTTS                                                                                        Laser photocoagulation                                  Case series               132            
  Ville,[110](#pd5421-bib-0110){ref-type="ref"} 1998                                          TTTS                                                                                        Laser photocoagulation                                  Case control              44             
  Weingertner,[111](#pd5421-bib-0111){ref-type="ref"} 2011                                    TTTS                                                                                        Laser photocoagulation                                  Case series               100            
  Wilson,[112](#pd5421-bib-0112){ref-type="ref"} 2016                                         TTTS                                                                                        Laser photocoagulation                                  Case series               151            
  Yamamoto,[113](#pd5421-bib-0113){ref-type="ref"} 2005                                       TTTS                                                                                        Laser photocoagulation                                  Case series               175            
  Yang,[114](#pd5421-bib-0114){ref-type="ref"} 2010                                           TTTS                                                                                        Laser photocoagulation                                  Case series               30             
  Zaretsky,[115](#pd5421-bib-0115){ref-type="ref"} 2018                                       TTTS                                                                                        Laser photocoagulation                                  Case series               749            
  Zhao,[116](#pd5421-bib-0116){ref-type="ref"} 2016                                           TTTS                                                                                        Laser photocoagulation                                  Case control              62             
  Multiple pregnancy complications treated with selective reduction                           Bebbington,[117](#pd5421-bib-0117){ref-type="ref"} 2012                                     TTTS, TRAP, sFGR, discordant anomaly                    RFA                       Case control   146
  Berg,[118](#pd5421-bib-0118){ref-type="ref"} 2014                                           TRAP                                                                                        RFA                                                     Case control              7              
  Delabaere,[119](#pd5421-bib-0119){ref-type="ref"} 2013                                      TTTS, TRAP, sFGR, discordant anomaly                                                        BCC, cord compression, cord ligation                    Case series               30             
  Deprest,[120](#pd5421-bib-0120){ref-type="ref"} 2000                                        TTTS, TRAP                                                                                  BCC                                                     Case series               10             
  Gallot,[121](#pd5421-bib-0121){ref-type="ref"} 2003                                         TTTS, TRAP                                                                                  CO                                                      Case series               11             
  Gouverneur,[122](#pd5421-bib-0122){ref-type="ref"} 2009                                     TTTS, TRAP, sFGR, discordant anomaly                                                        BCC, laser cord photocoagulation                        Case series               54             
  Gul,[123](#pd5421-bib-0123){ref-type="ref"} 2008                                            TTTS, TRAP, discordant anomaly                                                              BCC                                                     Case series               9              
  Has,[124](#pd5421-bib-0124){ref-type="ref"} 2014                                            TTTS, TRAP, sFGR, discordant anomaly                                                        BCC                                                     Case series               71             
  He,[125](#pd5421-bib-0125){ref-type="ref"} 2010                                             TTTS, TRAP, sFGR, discordant anomaly                                                        BCC                                                     Case series               14             
  Ilagan,[126](#pd5421-bib-0126){ref-type="ref"} 2008                                         TTTS, TRAP, discordant anomaly                                                              BCC                                                     Case series               27             
  Jelin,[127](#pd5421-bib-0127){ref-type="ref"} 2010                                          TRAP                                                                                        RFA                                                     Case control              7              
  King,[128](#pd5421-bib-0128){ref-type="ref"} 2017                                           TRAP, discordant anomaly                                                                    Laser cord photocoagulation                             Case series               43             
  Lanna,[129](#pd5421-bib-0129){ref-type="ref"} 2012                                          TTTS, TRAP, sFGR, discordant anomaly                                                        BCC                                                     Case series               118            
  Lee,[130](#pd5421-bib-0130){ref-type="ref"} 2013                                            TRAP                                                                                        RFA                                                     Case series               98             
  Lewi,[131](#pd5421-bib-0131){ref-type="ref"} 2006                                           TTTS, TRAP, sFGR, discordant anomaly                                                        Laser cord photocoagulation                             Case series               80             
  Moise,[132](#pd5421-bib-0132){ref-type="ref"} 2008                                          TTTS, discordant anomaly                                                                    RFA                                                     Case series               9              
  Nobili,[133](#pd5421-bib-0133){ref-type="ref"} 2013                                         Discordant anomaly                                                                          BCC                                                     Case series               48             
  Paramasivam,[134](#pd5421-bib-0134){ref-type="ref"} 2010                                    TTTS, TRAP, sFGR, discordant anomaly                                                        RFA                                                     Case series               35             
  Peng,[135](#pd5421-bib-0135){ref-type="ref"} 2016                                           TTTS, TRAP, sFGR, discordant anomaly, TAPS                                                  BCC                                                     Case control              93             
  Quintero,[136](#pd5421-bib-0136){ref-type="ref"} 1996                                       TTTS, TRAP, discordant anomaly                                                              CO                                                      Case series               13             
  Quintero,[137](#pd5421-bib-0137){ref-type="ref"} 2006                                       TRAP                                                                                        CO or laser photocoagulation                            Case control              51             
  Roman,[138](#pd5421-bib-0138){ref-type="ref"} 2010                                          TTTS, TRAP, sFGR, discordant anomaly                                                        RFA                                                     Case control              60             
  Schou,[139](#pd5421-bib-0139){ref-type="ref"} 2018                                          TTTS, TRAP, sFGR, discordant anomaly                                                        BCC                                                     Case control              102            
  Sugibayashi,[140](#pd5421-bib-0140){ref-type="ref"} 2016                                    TRAP                                                                                        RFA                                                     Case series               40             
  Takano,[141](#pd5421-bib-0141){ref-type="ref"} 2015                                         TRAP                                                                                        Laser photocoagulation +/− transection of cord (MCMA)   Case series               10             
  Taylor,[142](#pd5421-bib-0142){ref-type="ref"} 2002                                         TTTS                                                                                        BCC                                                     Case series               15             
  Tsao,[143](#pd5421-bib-0143){ref-type="ref"} 2002                                           TRAP                                                                                        RFA                                                     Case series               13             
  Zhang,[144](#pd5421-bib-0144){ref-type="ref"} 2018                                          TRAP                                                                                        RFA                                                     Case series               25             
  CDH                                                                                         Deprest,[145](#pd5421-bib-0145){ref-type="ref"} 2005                                        CDH                                                     FETO                      Case series    20
  Harrison,[52](#pd5421-bib-0052){ref-type="ref"} 1998[a](#pd5421-note-0006){ref-type="fn"}   CDH                                                                                         Tracheal clip                                           Case control              8              
  Harrison,[146](#pd5421-bib-0146){ref-type="ref"} 2003                                       CDH                                                                                         FETO                                                    Randomised                11             
  Jani,[147](#pd5421-bib-0147){ref-type="ref"} 2005                                           CDH                                                                                         FETO                                                    Case series               24             
  Jani,[148](#pd5421-bib-0148){ref-type="ref"} 2006                                           CDH                                                                                         FETO                                                    Case series               28             
  Jani,[149](#pd5421-bib-0149){ref-type="ref"} 2009                                           CDH                                                                                         FETO                                                    Case series               210            
  Jimenez,[150](#pd5421-bib-0150){ref-type="ref"} 2017                                        CDH                                                                                         Fetoscopic balloon removal                              Case control              201            
  Kosinski,[151](#pd5421-bib-0151){ref-type="ref"} 2017                                       CDH                                                                                         FETO                                                    Case series               28             
  Manrique,[152](#pd5421-bib-0152){ref-type="ref"} 2008                                       CDH                                                                                         FETO                                                    Case control              11             
  Peralta,[153](#pd5421-bib-0153){ref-type="ref"} 2011                                        CDH                                                                                         FETO                                                    Case series               8              
  Persico,[154](#pd5421-bib-0154){ref-type="ref"} 2017                                        CDH                                                                                         FETO                                                    Case series               21             
  Ruano,[155](#pd5421-bib-0155){ref-type="ref"} 2012                                          CDH                                                                                         FETO                                                    Case control              35             
  Ruano,[156](#pd5421-bib-0156){ref-type="ref"} 2012                                          CDH                                                                                         FETO                                                    Randomised                20             
  Ruano,[157](#pd5421-bib-0157){ref-type="ref"} 2013                                          CDH                                                                                         FETO                                                    Case control              17             
  MMC                                                                                         Arens,[158](#pd5421-bib-0158){ref-type="ref"} 2017                                          MMC                                                     Patch                     Case series    59
  Belfort,[159](#pd5421-bib-0159){ref-type="ref"} 2017                                        MMC                                                                                         Single layer suture (skin + dura)                       Case series               22             
  Bruner,[39](#pd5421-bib-0039){ref-type="ref"} 2000[a](#pd5421-note-0006){ref-type="fn"}     MMC                                                                                         Maternal skin graft                                     Case control              4              
  Degenhardt,[160](#pd5421-bib-0160){ref-type="ref"} 2014                                     MMC                                                                                         Patch                                                   Case series               51             
  Kohn,[161](#pd5421-bib-0161){ref-type="ref"} 2018                                           MMC                                                                                         Patch                                                   Case series               34             
  Pedreira,[162](#pd5421-bib-0162){ref-type="ref"} 2014                                       MMC                                                                                         Patch + skin suture                                     Case series               4              
  Pedreira,[163](#pd5421-bib-0163){ref-type="ref"} 2016                                       MMC                                                                                         Patch + skin suture                                     Case series               10             
  Verbeek,[164](#pd5421-bib-0164){ref-type="ref"} 2012                                        MMC                                                                                         Patch                                                   Case control              19             
  Ziemann,[165](#pd5421-bib-0165){ref-type="ref"} 2018                                        MMC                                                                                         Patch                                                   Case series               65             
  LUTO                                                                                        Morris,[166](#pd5421-bib-0166){ref-type="ref"} 2013                                         LUTO                                                    Vesicoamniotic shunting   Randomised     16
  Ruano,[167](#pd5421-bib-0167){ref-type="ref"} 2010                                          LUTO                                                                                        Cystoscopy                                              Case control              11             
  Welsh,[168](#pd5421-bib-0168){ref-type="ref"} 2003                                          LUTO                                                                                        Cystoscopy                                              Case series               13             
  Shunts                                                                                      Cavalheiro,[169](#pd5421-bib-0169){ref-type="ref"} 2011                                     Ventriculomegaly                                        Shunting                  Case series    30
  Mallman,[170](#pd5421-bib-0170){ref-type="ref"} 2017                                        Hydrothorax                                                                                 Shunting                                                Case series               78             
  Mixed                                                                                       Golombeck,[6](#pd5421-bib-0006){ref-type="ref"} 2006[a](#pd5421-note-0006){ref-type="fn"}   TTTS, TRAP, CDH, LUTO                                   Mixed                     Case control   99
  Kohl,[171](#pd5421-bib-0171){ref-type="ref"} 2006                                           MMC, CDH, CHAOS                                                                             Mixed                                                   Case series               16             
  Kohl,[172](#pd5421-bib-0172){ref-type="ref"} 2010                                           MMC, TTTS, CDH, CHAOS, ABS                                                                  Mixed                                                   Case series               37             
  Nivatpumin,[173](#pd5421-bib-0173){ref-type="ref"} 2016                                     TTTS, LUTO, CDH, TRAPS                                                                      Mixed                                                   Case series               152            
  Peralta,[174](#pd5421-bib-0174){ref-type="ref"} 2010                                        TTTS, CDH, TRAP                                                                             Mixed                                                   Case series               56             
  TOTAL                                                                                                                                                                                                                                                                     122 studies    9403 patients

Abbreviations: BCC, bipolar cord coagulation; CDH, congenital diaphragmatic hernia; CHAOS, congenital high airway obstruction syndrome; CO, cord occlusion; FETO, fetoscopic endoluminal tracheal occlusion; LUTO; lower urinary tract obstruction; MCMA, monochorionic monoamniotic; MMC, myelomeningocele; RFA, cord radiofrequency ablation; sFGR; selective fetal growth restriction; TAPS, twin anaemia‐polycythaemia sequence; TO, tracheal occlusion; TRAP, twin reversed arterial perfusion sequence; TTTS, twin‐to‐twin transfusion syndrome.

Studies including both open and fetoscopic procedures also included in Table [1](#pd5421-tbl-0001){ref-type="table"}.

###### 

Included studies of open and fetoscopic surgery focusing on late complications

  First Author and Year of Publication                                                      Type of Surgery   Condition                                   Study Design   Number of Patients
  ----------------------------------------------------------------------------------------- ----------------- ------------------------------------------- -------------- --------------------
  Farrell,[4](#pd5421-bib-0004){ref-type="ref"} 1999                                        Open              CDH, CCAM, LUTO, SCT,                       Case series    45
  Thom,[175](#pd5421-bib-0175){ref-type="ref"} 2016                                         Open              MMC                                         Randomised     87
  Wilson,[176](#pd5421-bib-0176){ref-type="ref"} 2010                                       Open              MMC, CCAM, CDH, SCT, mediastinal teratoma   Case series    47
  Zamora,[35](#pd5421-bib-0035){ref-type="ref"} 2013[a](#pd5421-note-0008){ref-type="fn"}   Open              MMC, lung mass, SCT, EXIT                   Case series    33
  Gregoir,[177](#pd5421-bib-0177){ref-type="ref"} 2016                                      Fetoscopic        CDH                                         Case control   89
  Le Lous,[178](#pd5421-bib-0178){ref-type="ref"} 2018                                      Fetoscopic        TTTS                                        Case control   122
  Vergote,[179](#pd5421-bib-0179){ref-type="ref"} 2018                                      Fetoscopic        TTTS                                        Case control   92
  TOTAL                                                                                                                                                   7 studies      515 patients

Abbreviations: CCAM, congenital cystic adenomatoid malformation; CDH, congenital diaphragmatic hernia; EXIT, ex utero intrapartum treatment; LUTO, lower urinary tract obstruction; MMC, myelomeningocele; SCT, sacrococcygeal teratoma; TTTS, twin‐to‐twin transfusion syndrome.

Studies including immediate and late complications, also included in Table [1](#pd5421-tbl-0001){ref-type="table"}.

3.3. Risk of bias {#pd5421-sec-0019}
-----------------

Quality assessment of the studies is given in the [Supporting Information](#pd5421-supitem-0001){ref-type="supplementary-material"}. Most studies (139/166, 83.7%) had a low risk of bias or were high quality. All remaining studies (27/166, 16.3%) had an unclear risk of bias or were fair quality. No studies were found to have a high risk of bias or be low quality overall. For randomised trials, included studies had a high risk of bias with regards to blinding. For case control studies, included studies did not describe statistical methods well overall.

3.4. Statistical heterogeneity {#pd5421-sec-0020}
------------------------------

Maternal outcome data were pooled in 64 separate meta‐analyses, of which 37.5% (24/64) had no or minor heterogeneity. In 39.1% (25/64), there was moderate heterogeneity, and in 23.4% (15/64), there was considerable heterogeneity. The levels of heterogeneity per outcome measure are listed in the [Supporting Information](#pd5421-supitem-0001){ref-type="supplementary-material"}. As both clinical and statistical heterogeneity were found, pooled proportions were given using the random effects model for meta‐analysis.

3.5. Maternal complications in the index pregnancy---intraoperative {#pd5421-sec-0021}
-------------------------------------------------------------------

Table [4](#pd5421-tbl-0004){ref-type="table"} summarises maternal complications according to type of surgery performed. No maternal deaths (Clavien‐Dindo grade V) due to fetal surgery were reported in any study (10 596 procedures). One study[86](#pd5421-bib-0086){ref-type="ref"} reported a patient at 20 weeks\' gestation experiencing a cardiorespiratory arrest prior to fetoscopy for laser photocoagulation. The cause was considered to be a combination of morbid obesity, spinal anaesthesia, and aortocaval compression and not related to the procedure, which had not commenced. An immediate delivery was conducted by hysterotomy as part of maternal resuscitation, and the patient made a full recovery. Another study[47](#pd5421-bib-0047){ref-type="ref"} reported brief maternal seizure‐like activity during open fetal surgery, which was thought to be anaesthesia‐related.

###### 

Maternal complications occurring with open or fetoscopic fetal surgery

                                                              Severe Complications                                  Minor Complications                     All Complications                                                                                                            
  ----------------------------------------------------------- ----------------------------------------------------- --------------------------------------- ---------------------------- ------------------------------------------------------------- --------------------------- ----- -----------------------------------------------------
  Clavien‐Dindo classification                                IV (requiring ICU care)                               III (requiring surgical intervention)   I‐II (requiring treatment)   I‐IV                                                                                            
  Open surgery n = 1193                                       Complication                                          n                                       Complication                 n                                                             Complication                n     **ALL COMPLICATIONS: 20.86% (95% CI, 15.22‐27.13)**
  Severe infection                                            2                                                     Haemorrhage requiring delivery          3                            Bleeding during procedure                                     13                                
  Pulmonary oedema                                            4                                                     Placental abruption                     28                           Transfusion during/after procedure                            41                                
  Complete heart block[a](#pd5421-note-0010){ref-type="fn"}   1                                                     Bowel obstruction                       1                            Chorioamnionitis/endometritis                                 45                                
                                                                                                                    Wound drainage                          2                            Other infections[b](#pd5421-note-0011){ref-type="fn"}         8                                 
                                                                                                                    Uterine rupture                         5                            Pulmonary oedema                                              50                                
                                                                                                                    Laparotomy/dehiscence repair            1                            Transfusion at delivery                                       17                                
                                                                                                                    Caesarean hysterectomy                  1                                                                                                                            
                                                                                                                                                                                                                                                                                         
  **TOTAL SEVERE: 4.51%** **(95% CI, 3.24‐5.98)**             **TOTAL MINOR: 16.26%** **(95% CI, 11.17‐22.09)**                                                                                                                                                                          
  Fetoscopic surgery n = 9403                                 Maternal cardiac arrest and delivery by hysterotomy   1                                       Sepsis requiring delivery    1                                                             Bleeding during procedure   165   **ALL COMPLICATIONS: 6.15% (95% CI, 4.93‐7.49)**
  Severe infection                                            2                                                     Haemorrhage requiring delivery          8                            Transfusion during/after procedure                            16                                
  Pulmonary oedema                                            3                                                     Placental abruption                     159                          Venous thromboembolism[c](#pd5421-note-0012){ref-type="fn"}   2                                 
  Lung collapse                                               1                                                                                                                          Chorioamnionitis                                              114                               
  DIC + caesarean hysterectomy                                1                                                                                                                          Other infections[d](#pd5421-note-0013){ref-type="fn"}         2                                 
  Amniotic fluid embolism                                     2                                                                                                                          Pulmonary oedema                                              45                                
                                                                                                                                                                                         Upper GI bleed[e](#pd5421-note-0014){ref-type="fn"}           1                                 
                                                                                                                                                                                         Diathermy skin burns                                          4                                 
                                                                                                                                                                                         "Epidural headache" + blood patch                             1                                 
                                                                                                                                                                                         Wound hernia                                                  1                                 
                                                                                                                                                                                         Pleural effusions                                             1                                 
                                                                                                                                                                                                                                                                                         
  **TOTAL SEVERE: 1.66%** **(95% CI, 1.19‐2.20)**             **TOTAL MINOR: 4.33%** **(95% CI, 3.33‐5.45)**                                                                                                                                                                             

Abbreviations: CI, confidence interval; GI, gastrointestinal; n, number of women. Pooled proportions calculated using random effect model for meta‐analysis.

Complete heart block considered to be tocolysis‐related (magnesium sulphate).

Other infections in open surgery: wound (6), chest (1), urinary tract (1).

Venous thromboembolism: confirmed pulmonary embolism (1); suspected PE with confirmed deep vein thrombosis (1).

Other infections in fetoscopic surgery: wound (1), chest (1).

Upper GI bleed considered to be tocolysis‐related (indomethacin).

Haemorrhage severe enough to prompt delivery or termination of pregnancy at the time of surgery as a life‐saving procedure for the mother (Clavien‐Dindo grade III) occurred in 0.92% of open fetal (95% CI, 0.46‐1.62) and 0.26% of fetoscopic surgeries (95% CI, 0.17‐0.38). Three cases[38](#pd5421-bib-0038){ref-type="ref"}, [45](#pd5421-bib-0045){ref-type="ref"}, [46](#pd5421-bib-0046){ref-type="ref"} occurred because of placental abruption during open fetal surgery for myelomeningocele (MMC) repair, following which delivery occurred, with all three fetuses surviving. Two cases[59](#pd5421-bib-0059){ref-type="ref"}, [75](#pd5421-bib-0075){ref-type="ref"} occurred following laser photocoagulation for TTTS said to be due to "excessive bleeding from placental anastomoses" and the uterine wall, respectively. Two cases[119](#pd5421-bib-0119){ref-type="ref"}, [121](#pd5421-bib-0121){ref-type="ref"} occurred during selective reduction, with haemorrhage from the uterine wall prompting delivery. Finally, one pregnancy was terminated because of bleeding from a trocar placental injury during fetoscopic MMC repair.[172](#pd5421-bib-0172){ref-type="ref"}

In total, placental abruption (Clavien‐Dindo grade III) occurred intraoperatively in 1.28% of open fetal (95% CI, 0.73‐1.98) and in 0.28% of fetoscopic surgeries (95% CI, 0.18‐0.39). Bleeding during the procedure was noted in 1.97% of open fetal (95% CI, 0.97‐3.31) and in 1.74% of fetoscopic surgery cases (95% CI, 1.25‐2.32). Intraoperative blood transfusion was required in 1.00% of patients undergoing open fetal surgery (95% CI, 0.53‐1.64) and in 0.27% undergoing fetoscopic surgery (95% CI, 0.18‐0.38). Intraoperative skin burns at the site of diathermy pads occurred in 0.26% of patients (95% CI, 0.17‐0.37) during fetoscopic surgery; this outcome was not reported in any open fetal surgery.

3.6. Maternal complications in the index pregnancy---postoperative {#pd5421-sec-0022}
------------------------------------------------------------------

One study on laser photocoagulation for TTTS (n = 132)[110](#pd5421-bib-0110){ref-type="ref"} reported a maternal death from disseminated intravascular coagulation (DIC) 4 weeks following an uneventful procedure. A post‐mortem examination did not find any evidence of chorioamnionitis or amniotic fluid embolism, and the authors therefore concluded that this death was unrelated to the procedure.

Haemorrhage severe enough to prompt return to theatre for termination or delivery of the pregnancy within 24 hours was not reported following any open fetal surgeries but occurred following 0.25% of fetoscopic procedures (95% CI, 0.16‐0.37). This included one[171](#pd5421-bib-0171){ref-type="ref"} 4‐hour post‐fetoscopic tracheal balloon removal with no cause of the bleeding found. There were two late placental abruptions, one[113](#pd5421-bib-0113){ref-type="ref"} 12‐hour post‐laser photocoagulation, and one[142](#pd5421-bib-0142){ref-type="ref"} within 24 hours of bipolar cord coagulation.

Placental abruption occurred in 1.80% of patients following open fetal (95% CI, 1.14‐2.63) and in 1.29% following fetoscopic surgery (95% CI, 0.90‐1.75). Post‐operative blood transfusion was given to 3.36% after open fetal surgery (95% CI, 1.85‐5.29) and in 0.32% following fetoscopic surgery (95% CI, 0.22‐0.44).

Chorioamnionitis following open fetal surgery or endometritis following an EXIT procedure occurred in 4.13% of women (95% CI, 3.03‐5.40), and in 1.45% undergoing fetoscopic surgery (95% CI, 1.06‐1.90). Of those, PROM was reported to have occurred in 47.78% following open fetal surgery (95% CI, 23.01‐73.16) and in 36.31% following fetoscopic surgery (95% CI, 22.00‐51.99). One study reported severe chorioamnionitis 5 days after bipolar cord coagulation[131](#pd5421-bib-0131){ref-type="ref"} with septic shock and acute kidney injury, which resolved leaving 70% residual renal function. Sepsis was also reported in one patient[61](#pd5421-bib-0061){ref-type="ref"} with chorioamnionitis following fetoscopic laser photocoagulation and in one patient[49](#pd5421-bib-0049){ref-type="ref"} following open MMC repair who developed post‐operative peritonitis requiring an emergency laparotomy and delivery. Post‐operative pneumonia occurred in two patients---one[132](#pd5421-bib-0132){ref-type="ref"} following fetoscopic radiofrequency ablation (RFA), necessitating 3 days of intubation and intensive care unit (ICU) care and one requiring ICU admission[36](#pd5421-bib-0036){ref-type="ref"} following open MMC repair.

Pulmonary oedema occurred in 4.32% of open fetal surgery cases (95% CI, 2.32‐6.90), and in 0.63% of fetoscopic cases (95% CI, 0.43‐0.87). Three studies in which post‐operative pulmonary oedema occurred reported on perioperative fluid management (3/102, 2.9%), and 33 reported on the use of magnesium sulphate (33/102, 32.4%) without specifically suggesting causality. Six women required ICU admission, with four requiring intubation and ventilation; three following open fetal surgery,[6](#pd5421-bib-0006){ref-type="ref"}, [20](#pd5421-bib-0020){ref-type="ref"} and three following fetoscopic surgery.[69](#pd5421-bib-0069){ref-type="ref"}, [87](#pd5421-bib-0087){ref-type="ref"}, [99](#pd5421-bib-0099){ref-type="ref"}

3.7. Maternal complications in the index pregnancy---at delivery {#pd5421-sec-0023}
----------------------------------------------------------------

Only a few fetoscopic surgery studies (4/121 studies, 0.33%) reported findings or complications at delivery. Complications at delivery following open fetal surgery are shown in Table [4](#pd5421-tbl-0004){ref-type="table"}. Hysterectomy at or around the time of delivery was reported in two patients (Clavien‐Dindo grade III). In one case,[44](#pd5421-bib-0044){ref-type="ref"} caesarean delivery following open MMC repair in a woman with two previous caesareans, intra‐abdominal scarring and friable tissue eventually resulted in hysterectomy. In the second case,[99](#pd5421-bib-0099){ref-type="ref"} following laser photocoagulation for TTTS and PROM, a caesarean section was performed at 33 weeks\' gestation. A hysterectomy was eventually required because of haemorrhage with DIC, and the patient spent 5 days in ICU, where she also experienced an iatrogenic pneumothorax.

Uterine rupture occurred in 0.90% of patients at delivery following open fetal surgery (excluding EXIT procedures) in the index pregnancy (95% CI, 0.41‐1.59), and uterine dehiscence occurred in 3.67% (95% CI, 2.01‐5.81). Blood transfusion was given to 1.83% of women (95% CI, 1.16‐2.65) at delivery following open fetal surgery.

3.8. Overall maternal complication rates {#pd5421-sec-0024}
----------------------------------------

Table [4](#pd5421-tbl-0004){ref-type="table"} displays maternal complications. In open fetal surgery, there was a 4.51% severe (95% CI, 3.24‐5.98), a 16.26% minor complication rate (95% CI, 11.17‐22.09), and a total complication rate of 20.86% (95% CI, 15.22‐27.13). For fetoscopic surgery, the corresponding rates were: 1.66% severe (95% CI, 1.19‐2.20), 4.33% minor (95% CI, 3.33‐5.45), and 6.15% total complications (95% CI, 4.93‐7.49). Complication rates in the six commonest fetal surgical procedures performed are displayed in Table [5](#pd5421-tbl-0005){ref-type="table"}.

###### 

Maternal complications according to type of fetal surgery in the six most common procedures

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                       Severe Complications                           Minor Complications                     All Complications                                                                                                          
  ---------------------------------------------------- ---------------------------------------------- --------------------------------------- -------------------------------- ------------------------------------------------------- --------------------------- ----- ----------------------------------------------------
  Clavien‐Dindo classification                         IV (requiring ICU care)                        III (requiring surgical intervention)   I‐II (requiring treatment)       I‐IV                                                                                      

  EXIT n = 237                                         Complication                                   n                                       Complication                     n                                                       Complication                n     **ALL COMPLICATIONS: 20.19% (95% CI, 4.93‐7.49)**

                                                                                                      Placental abruption                     5                                Bleeding during procedure                               11                                

                                                                                                                                                                               Transfusion during/after procedure                      19                                

                                                                                                                                                                               Endometritis                                            10                                

                                                                                                                                                                               Wound infection                                         5                                 

                                                                                                                                                                                                                                                                         

  **TOTAL SEVERE: 3.62% (95% CI, 1.69‐6.24)**          **TOTAL MINOR: 17.53% (95% CI, 9.86‐26.86)**                                                                                                                                                                      

  Open MMC repair n = 779                              Severe infection                               2                                       Haemorrhage requiring delivery   3                                                       Bleeding during procedure   1     **ALL COMPLICATIONS: 11.54% (95% CI, 7.73‐15.99)**

  Complete heart block                                 1                                              Placental abruption                     16                               Transfusion during/after procedure                      5                                 

  Pulmonary oedema                                     1                                              Bowel obstruction                       1                                Chorioamnionitis                                        21                                

                                                                                                      Uterine rupture                         4                                Other infections[a](#pd5421-note-0016){ref-type="fn"}   2                                 

                                                                                                      Caesarean hysterectomy                  1                                Pulmonary oedema                                        15                                

                                                                                                                                                                               Transfusion at delivery                                 16                                

                                                                                                                                                                                                                                                                         

  **TOTAL SEVERE: 3.35% (95% CI, 1.70‐5.53)**          **TOTAL MINOR: 6.63% (95% CI, 3.63‐10.45)**                                                                                                                                                                       

  Fetoscopic MMC repair n = 268                                                                                                               Placental abruption              6                                                       Bleeding during procedure   3     **ALL COMPLICATIONS: 12.49% (95% CI, 4.83‐23.06)**

                                                                                                                                                                               Chorioamnionitis                                        10                                

                                                                                                                                                                               Pulmonary oedema                                        5                                 

                                                                                                                                                                                                                                                                         

  **TOTAL SEVERE: 2.75% (95% CI, 0.56‐6.52)**          **TOTAL MINOR: 9.04% (95% CI, 3.27‐17.40)**                                                                                                                                                                       

  FETO (insertion or fetoscopic removal of balloon)\                                                                                          Placental abruption              4                                                       Bleeding during procedure   1     **ALL COMPLICATIONS: 3.44% (95% CI, 0.98‐7.32)**
  n = 634                                                                                                                                                                                                                                                                

                                                                                                                                                                               Transfusion during/after procedure                      1                                 

                                                                                                                                                                               Chorioamnionitis                                        7                                 

                                                                                                                                                                               Wound infection                                         1                                 

                                                                                                                                                                               Pulmonary oedema                                        3                                 

                                                                                                                                                                                                                                                                         

  **TOTAL SEVERE: 1.08% (95% CI, 0.23‐2.54)**          **TOTAL MINOR: 2.39% (95% CI, 0.71‐5.02)**                                                                                                                                                                        

  Fetoscopic laser photo‐coagulation n = 6746          Maternal arrest and delivery                   1                                       Haemorrhage requiring delivery   2                                                       Bleeding during procedure   148   **ALL COMPLICATIONS: 5.86% (95% CI, 4.33‐7.61)**

  Pulmonary oedema                                     3                                              Sepsis requiring delivery               1                                Transfusion during/after procedure                      9                                 

  Lung collapse                                        1                                              Placental abruption                     130                              VTE[b](#pd5421-note-0017){ref-type="fn"}                2                                 

  Amniotic fluid embolism                              2                                                                                                                       "Epidural headache" + blood patch                       1                                 

  DIC + caesarean hysterectomy                         1                                                                                                                       Chorioamnionitis                                        68                                

                                                                                                                                                                               Pulmonary oedema                                        11                                

                                                                                                                                                                               Upper GI bleed[c](#pd5421-note-0018){ref-type="fn"}     1                                 

                                                                                                                                                                               Wound hernia                                            1                                 

                                                                                                                                                                                                                                                                         

  **TOTAL SEVERE: 1.51% (95% CI, 0.91‐2.25)**          **TOTAL MINOR: 4.03% (95% CI, 2.73‐5.56)**                                                                                                                                                                        

  Fetoscopic selective reduction n = 1239              Severe infection                               2                                       Haemorrhage requiring delivery   3                                                       Bleeding during procedure   10    **ALL COMPLICATIONS: 5.20% (95% CI, 3.00‐7.96)**

                                                                                                      Placental abruption                     14                               Diathermy skin burns                                    4                                 

                                                                                                                                                                               Chorioamnionitis                                        19                                

                                                                                                                                                                               Chest infection                                         1                                 

                                                                                                                                                                               Pleural effusion                                        1                                 

                                                                                                                                                                                                                                                                         

  **TOTAL SEVERE: 1.98% (95% CI, 0.97‐3.35)**          **TOTAL MINOR: 3.00% (95% CI, 1.68‐4.68)**                                                                                                                                                                        
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: DIC, disseminated intravascular coagulation; EXIT, ex utero intrapartum treatment; FETO, fetoscopic endoluminal tracheal occlusion; GI, gastrointestinal; MMC, myelomeningocele; n, number of women. Pooled proportions calculated using random effect model for meta‐analysis.

Other infections in MMC surgery: chest (1), urinary tract (1).

Venous thromboembolism: confirmed pulmonary embolism (1); suspected PE with confirmed deep vein thrombosis (1).

Upper GI bleed considered to be tocolysis‐related (indomethacin).

3.9. Maternal outcomes following the index pregnancy (long‐term) {#pd5421-sec-0025}
----------------------------------------------------------------

Table [6](#pd5421-tbl-0006){ref-type="table"} shows subsequent pregnancy outcomes and long‐term maternal outcomes following a pregnancy in which fetal surgery was performed. New difficulties in conceiving were described in 3.81% of women after open fetal surgery (95% CI, 1.22‐7.76, reported in four studies); this outcome was not reported to occur after fetoscopic surgery (three studies). Pregnancy loss prior to 24 weeks\' gestation occurred in 19.95% of pregnancies conceived following open fetal surgery (95% CI, 13.37‐27.48, three studies) and 13.67% of pregnancies conceived after fetoscopic surgery (95% CI, 9.34‐18.68, three studies). Preterm birth occurred in 20.49% of pregnancies following open fetal surgery (95% CI, 10.48‐32.81, four studies) and in 2.12% of pregnancies following fetoscopic surgery (95% CI, 0.02‐9.01; three studies). Uterine rupture or dehiscence occurred, respectively, in 6.89% (95% CI, 1.34‐16.27, reported in three studies) and 11.09% (95% CI, 5.34‐18.59) of pregnancies following open fetal surgery. None were mentioned in fetoscopy studies.

###### 

Long‐term maternal complications following open and fetoscopic fetal surgery

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                            **Open Surgery** [a](#pd5421-note-0020){ref-type="fn"}\   **Fetoscopic Surgery** [b](#pd5421-note-0021){ref-type="fn"}\
                                                                                                            % (95% CI)                                                % (95% CI)
  ------------------------------------------------------------- ------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------------
  Conception                                                    Women attempting further pregnancy          50.11 (21.55‐78.63)                                       51.76 (18.63‐84.03)

  Women conceiving further pregnancy                            48.33 (26.74‐70.26)                         48.20(31.46‐65.16)                                        

  New sub‐fertility                                             3.81(1.22‐7.76)                             NR                                                        

  Pregnancy outcomes                                            Miscarriage                                 19.95 (13.37‐27.48)                                       13.67 (9.34‐18.68)

  Preterm delivery                                              20.49 (10.48‐32.81)                         2.12 (0.02‐9.01)                                          

  Uterine rupture                                               6.89 (1.34‐16.27)                           0                                                         

  Uterine dehiscence                                            11.09 (5.34‐18.59)                          NR                                                        

  Excessive bleeding at delivery                                6.84 (2.16‐13.88)                           5.52 (2.83‐9.03)                                          

  Nonpregnancy                                                  Abdominal pain                              6.38[b](#pd5421-note-0021){ref-type="fn"}                 9.01 (3.84‐16.06)

  Abnormal menstrual bleeding                                   NR                                          6.54 (3.43‐10.57)                                         

  Gynaecological surgery[c](#pd5421-note-0022){ref-type="fn"}   8.68 (1.81‐19.96)                           NR                                                        

  Psychological symptoms                                        9.09[b](#pd5421-note-0021){ref-type="fn"}   32.56 (7.70‐64.58)                                        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviation: NR, not reported. Pooled proportions calculated using random effect model for meta‐analysis.

Variable denominator as not all outcomes were reported by all studies.

No meta‐analysis possible as reported by single study.

Gynaecological surgery following open fetal surgery: endometrial ablation (1), hysterectomy (6): caesarean hysterectomy (1), ovarian cysts+/−menstrual disorder (2), fibroids (1), unknown reason (2).

4. DISCUSSION {#pd5421-sec-0026}
=============

In this systematic review of the literature, we found an overall complication rate of approximately 21% for open fetal surgery and 6% for fetoscopic fetal surgery, of which minor complications occurred in 16% and 4% of surgeries, respectively. This maternal complication rate excludes obstetric complications, which may also have occurred (eg, PROM, CMS, preterm labour, and preterm delivery). Additionally, many studies of fetal surgery fail to document maternal complications. Out of 751 full‐text articles reviewed, 175 (23.3%) were excluded as no maternal outcomes were stated. Although 68 of these studies focused on a specific aspect of the surgery or its neonatal outcome, 107 studies (92 fetoscopic and 15 open) involving over 9000 patients did not comment on the presence or absence of any complications specifically affecting the mother\'s health. Often, the "maternal outcomes" stated meant in reality obstetric outcomes (eg, PROM and preterm labour). We also found that maternal complications were often presented from the fetal perspective (eg, fetal demise caused by placental abruption). Thirty included studies (18.1%) contained a statement that no adverse maternal outcomes were observed without specifying what was meant by maternal outcomes. Among these studies were some large series, including a study of 201 patients undergoing fetoscopic tracheal balloon removal[150](#pd5421-bib-0150){ref-type="ref"} and studies of 200[73](#pd5421-bib-0073){ref-type="ref"} and 500[81](#pd5421-bib-0081){ref-type="ref"} patients undergoing fetoscopic laser coagulation. It is unlikely that such large numbers of procedures had no maternal complications, and more likely that complications were either not perceived as serious, not reported and/or the patient follow‐up was incomplete. This lack of reporting has most likely led to an underestimation of the actual risk of maternal complications in our meta‐analysis. Conversely, when maternal complications were reported, there was a wide variability in which outcomes were discussed and how they were presented.

There was a severe complication rate (Clavien‐Dindo grade III or IV) of 4.5% in women undergoing open fetal surgery and 1.7% undergoing fetoscopic surgery. This is in keeping with a previous multi‐centre review of maternal complications following laser photocoagulation for TTTS,[7](#pd5421-bib-0007){ref-type="ref"} which found a 1.0% rate of severe complications and a 5.4% total rate of complications across all studies; however, when the authors only included studies, which systematically assessed maternal complications as a primary or secondary outcome, this rose to 1.8% for severe and 17.4% for all complications.

In almost all studies of fetal surgery reviewed, long‐term maternal follow up was not described. The seven studies that did so had a wide variation in the parameters described. Fertility does not appear to be negatively affected by fetal surgery, with the rates of de novo difficulties for conceiving in this review (3.81% following open fetal surgery and none following fetoscopic surgery) being comparable, if not less, than published rates of secondary infertility in the general population.[180](#pd5421-bib-0180){ref-type="ref"} Similarly, the rates of miscarriage described (19.85% following open fetal and 13.67% following fetoscopic surgery) are similar to rates of spontaneous miscarriage in women who have not undergone fetal surgery.[181](#pd5421-bib-0181){ref-type="ref"}, [182](#pd5421-bib-0182){ref-type="ref"}, [183](#pd5421-bib-0183){ref-type="ref"} Epidemiological studies[184](#pd5421-bib-0184){ref-type="ref"} have suggested a worldwide preterm birth rate of 11.1% with a rate of 8.6% in "developed regions."[184](#pd5421-bib-0184){ref-type="ref"} In the United States and United Kingdom, it is estimated at 9.8%[185](#pd5421-bib-0185){ref-type="ref"} and 7.3%,[186](#pd5421-bib-0186){ref-type="ref"} respectively. The preterm birth rate in this review following open fetal surgery (20.49%) is higher than the usual prevalence, but not higher following fetoscopic surgery (2.12%). Open fetal surgery was followed by uterine rupture or dehiscence in 6.89% and 11.09% of subsequent pregnancies, respectively, which is in line with published rates of rupture (6.2%) and dehiscence (12.5%) following a classical caesarean section.[187](#pd5421-bib-0187){ref-type="ref"} Conversely, no uterine ruptures were reported following fetoscopic surgery.

This study included the commonest fetal procedures and, from a maternal perspective, involved similar surgical manipulations yet variable operating times. We included studies from multiple centres worldwide and attempted to identify the non‐English literature. It is therefore likely that these results are generalisable to fetal surgery performed outside the included studies. An obvious weakness of this systematic review is that most studies did not include a control group. Furthermore, we decided to pool data for meta‐analysis despite having high heterogeneity in some results. Another weakness is the extraction of patient data from papers, which is prone to error given the variable reporting; it is possible that some patients had more than one complication and this was not noted or cumulative rates were as a consequence miscalculated.

This systematic review has identified a significant rate of maternal complications, which should be discussed with patients before embarking on fetal surgery. Large studies allow an estimation of the likelihood of these events, insomuch as the cases in these series are unselected and consecutive. Our systematic review search strategy may have missed relevant yet rare complications. For example, a letter to a journal editor describing maternal convulsions during general anaesthesia[188](#pd5421-bib-0188){ref-type="ref"} was excluded as a case report according to our criteria. In this circumstance, it appears that the patient was also part of the cohort of a study that was included,[47](#pd5421-bib-0047){ref-type="ref"} but it is possible that other rare events published as case reports have been missed. An international, prospective registry of fetal and fetoscopic surgery, such as the Eurofoetus[189](#pd5421-bib-0189){ref-type="ref"} and NAFTNet[190](#pd5421-bib-0190){ref-type="ref"} registries, would be the best way to accurately determine complication types and rates and avoid missing rare complications.

5. CONCLUSION {#pd5421-sec-0027}
=============

The maternal risks of fetal surgery are accepted by many patients and health care professionals for the possible benefit to the fetus.[191](#pd5421-bib-0191){ref-type="ref"}, [192](#pd5421-bib-0192){ref-type="ref"} This systematic review finds that studies of fetal surgery focus on the fetal outcomes of the procedure, and many fail to describe maternal complications. Fetal surgery comes at a risk to the mother, which may be underestimated by fetal therapists because of under‐reporting and variable reporting quality. In order to properly quantify maternal risks, outcomes should be reported consistently across all studies of fetal surgery, preferentially in prospective registries.
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